Reid M. Huber

Insider Reports History

Entity
Individual
Location
C/O Incyte Corporation, Experimental Stn, Route 141 & Henry Clay Road, Bldg. E336, Wilmington, DE
Signature
/s/ Cheryl Gault, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Reid M. Huber:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tango Therapeutics, Inc. Director Common Stock 5K $42K $8.39 Jun 6, 2023 Direct
BELLICUM PHARMACEUTICALS, INC Director Stock Option (right to buy) 15K $21.6K $1.44 Jun 15, 2022 Direct
BELLICUM PHARMACEUTICALS, INC Director Common Stock 147K Jan 3, 2023 Direct
Tango Therapeutics, Inc. Director Stock Option (Right to Buy) 30K Jun 6, 2023 Direct
CARGO Therapeutics, Inc. Director Stock Option (Right to Buy) 23.7K Jun 4, 2024 Direct

Insider Reports Filed by Reid M. Huber

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 0 $0 3 Jun 6, 2024 Director
CRGX CARGO Therapeutics, Inc. Jun 4, 2024 1 $0 4 Jun 6, 2024 Director
CRGX CARGO Therapeutics, Inc. Nov 9, 2023 1 $0 4 Nov 13, 2023 Director
CRGX CARGO Therapeutics, Inc. Nov 9, 2023 0 $0 3 Nov 9, 2023 Director
TNGX Tango Therapeutics, Inc. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
BLCM BELLICUM PHARMACEUTICALS, INC Jan 3, 2023 1 $0 4/A Jan 20, 2023 Director
BLCM BELLICUM PHARMACEUTICALS, INC Sep 1, 2022 1 $0 4 Sep 2, 2022 Director
BLCM BELLICUM PHARMACEUTICALS, INC Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
TNGX Tango Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 28, 2022 Director
BLCM BELLICUM PHARMACEUTICALS, INC Jan 4, 2022 2 $0 4 Jan 6, 2022 Director
TNGX Tango Therapeutics, Inc. Aug 10, 2021 0 $0 3 Aug 12, 2021 Director
BLCM BELLICUM PHARMACEUTICALS, INC Jun 15, 2021 1 $0 4 Jul 7, 2021 Director